ConductScience.org, home
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
API referenceFor AI assistants

Trial · NCT01799889

Adverse events5,736

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 5,736

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersCLL: Entospletinib MM/SDD1241
otherAnaemiaBlood and lymphatic system disordersFL: Entospletinib MM/SDD741
otherAnaemiaBlood and lymphatic system disordersDLBCL: Entospletinib MM/SDD1143
otherAnaemiaBlood and lymphatic system disordersMCL: Entospletinib MM/SDD639
otherAnaemiaBlood and lymphatic system disordersNon-FL iNHL: Entospletinib MM/SDD949
otherAnaemiaBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 100 mg619
otherAnaemiaBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 200 mg721
otherAnaemiaBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 400 mg320
otherAnaemiaBlood and lymphatic system disordersCLL (Non-Richters) Prior BTK Inhibitor: Entospletinib SDD1333
otherAnaemiaBlood and lymphatic system disordersCLL (Non-Richters) Prior PI3K Inhibitor: Entospletinib SDD18
otherAnaemiaBlood and lymphatic system disordersCLL (Richters) Prior BTK Inhibitor: Entospletinib SDD26
otherAnaemiaBlood and lymphatic system disordersCLL (Richters) Prior PI3K Inhibitor: Entospletinib SDD03
otherHaemolysisBlood and lymphatic system disordersCLL: Entospletinib MM/SDD041
otherHaemolysisBlood and lymphatic system disordersFL: Entospletinib MM/SDD041
otherHaemolysisBlood and lymphatic system disordersDLBCL: Entospletinib MM/SDD043
otherHaemolysisBlood and lymphatic system disordersMCL: Entospletinib MM/SDD039
otherHaemolysisBlood and lymphatic system disordersNon-FL iNHL: Entospletinib MM/SDD049
otherHaemolysisBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 100 mg119
otherHaemolysisBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 200 mg021
otherHaemolysisBlood and lymphatic system disordersCLL, Prior BCR Inhibitor Naive: Entospletinib SDD 400 mg020

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01799889/events

API referenceFor AI assistants